NCT04867200View on ClinicalTrials.gov

A Clinical Study to Evaluate the Safety and Pharmacokinetics of CKD-344 in Healthy Volunteers

PHASE1UnknownINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

April 27, 2021

Primary Completion Date

May 25, 2021

Study Completion Date

June 1, 2021

Conditions
Anticoagulant
Interventions
DRUG

Lixiana(D006)

NOAC(Factor Xa inhibitor)

DRUG

CKD-344

NOAC(Factor Xa inhibitor)

Trial Locations (1)

Unknown

RECRUITING

H+ Yangji Hospital, Seoul

Sponsors
All Listed Sponsors
lead

Chong Kun Dang Pharmaceutical

INDUSTRY